Park Amy J, Paraiso Marie Fidela R
Female Pelvic Medicine & Reconstructive Pelvic Surgery and Minimally Invasive Surgery, Department of Gynecology & Obstetrics, Cleveland Clinic, Cleveland, Ohio.
Obstet Gynecol. 2009 Aug;114(2 Pt 2):484-487. doi: 10.1097/AOG.0b013e3181998ce1.
Refractory dyspareunia presents a challenging therapeutic dilemma.
A woman with defecatory dysfunction and dyspareunia presented with stage 2 prolapse. She underwent laparoscopic and vaginal pelvic floor reconstruction with excision of endometriosis. The patient experienced increased dyspareunia and de novo vaginismus postoperatively that were refractory to trigger point injections, physical therapy, and medical and surgical management. She underwent botulinum toxin type A injections into her levator ani muscles, which allowed her to have sexual intercourse again after 2 years of apareunia with no recurrence of pain for 12 months.
Injecting botulinum toxin into the levator ani muscles shows promise for postoperative patients who develop vaginismus and do not respond to conservative therapy.
难治性性交困难带来了具有挑战性的治疗难题。
一名患有排便功能障碍和性交困难的女性出现2期脱垂。她接受了腹腔镜和阴道盆底重建术并切除子宫内膜异位症。患者术后性交困难加重且出现新发性阴道痉挛,对触发点注射、物理治疗以及药物和手术治疗均无效。她接受了A型肉毒杆菌毒素注射到提肛肌,这使她在两年无性交后再次能够进行性交,且12个月内疼痛未复发。
向提肛肌注射肉毒杆菌毒素对术后发生阴道痉挛且对保守治疗无反应的患者显示出前景。